S-Network Medical Breakthroughs Index
An index of small and mid-cap biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.
Quick Links
| As June 7, 2023 | Index Level | 3-Month | 6-Month | 1-Year | YTD |
| Price Return | 7,424.2 | 11.3% | 11.3% | 22.7% | 8.5% |
| Total Return | |||||
| Net Total Return |
| Index Level | 7,424.2 |
|---|---|
| 3-Month | 11.3% |
| 6-Month | 11.3% |
| 1-Year | 22.7% |
| YTD | 8.5% |
| Index Level | |
|---|---|
| 3-Month | |
| 6-Month | |
| 1-Year | |
| YTD |
| Index Level | |
|---|---|
| 3-Month | |
| 6-Month | |
| 1-Year | |
| YTD |
As of June 7, 2023
Characteristics
| Index Symbol (Price Return) | PMBI |
| Index Symbol (Total Return) | NA |
| Index Symbol (Net Total Return) | PMBINT |
| Number of Constituents | 113 |
| Market Capitalization | $177 Billion |
| Adjusted Market Capitalization | $116 Million |
| Rebalancings | Quarterly |
| Dividend Yield | 0.0% |
Resources
Composition
Top Index Constituents
As of June 8, 2023
Interested in Market Data packages?
VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.
Contact Us